Search company, investor...

NeuroVive

neurovive.com

Stage

PIPE | IPO

About NeuroVive

NeuroVive is a pharmaceutical company focused on mitochondrial medicine, a very exciting area which is about to create a paradigm shift in medicine development. The company is dedicated to continuously developing the platform of pharmaceutical products that the company's operations are based.

Headquarters Location

Medicon Village Scheelevagen 2

Lund, SE-223 81,

Sweden

+46 (0) 46 275 62 20

Missing: NeuroVive's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NeuroVive's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

NeuroVive Patents

NeuroVive has filed 1 patent.

The 3 most popular patent topics include:

  • Abandoned drugs
  • Androgens and anabolic steroids
  • Clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/8/2015

10/19/2021

Small nuclear RNA, Cellular respiration, Cell biology, Glucocorticoids, Metabolism

Grant

Application Date

4/8/2015

Grant Date

10/19/2021

Title

Related Topics

Small nuclear RNA, Cellular respiration, Cell biology, Glucocorticoids, Metabolism

Status

Grant

Latest NeuroVive News

Global Cyclophilin Inhibitors Therapeutics Market Technological Advancements To Watch Out For Near Future – Global Industry Analysis 2028 | Cypralis Limited, NeuroVive, ContraVir Pharmaceuticals, Hepion Pharmaceuticals

May 7, 2021

Search jobs 07-May-2021 Global Cyclophilin Inhibitors Therapeutics Market Technological Advancements To Watch Out For Near Future – Global Industry Analysis 2028 | Cypralis Limited, NeuroVive, ContraVir Pharmaceuticals, Hepion Pharmaceuticals “Global Cyclophilin Inhibitors Therapeutics Market” report presents the best market and business solutions to Industry in this rapidly revolutionizing marketplace to thrive in the market. This market research report is a vigilant investigation of the current scenario of the market and future estimations which spans several market dynamics. The market definition gives the scope of a particular product with respect to the driving factors and restraints in the market. This industry document forecasts the size of the market with information on key vendor revenues, development of the industry by upstream and downstream, industry progress, key companies, along market segment type and market application. Key data and information used while preparing this market report have been collected from consistent sources that range from journals, websites, research papers, case studies, and magazines. Cyclophilin inhibitors therapeutics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 9.4% in the forecast mentioned above period. Increasing the prevalence of  HCV  disorders and family history of  hepatitis C  will assist in encouraging the growth of the market. Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cyclophilin-inhibitors-therapeutics-market Major Key Competitors: The major players operating in the cyclophilin inhibitors therapeutics market report are Ciclofilin Pharmaceuticals, Cypralis Limited, NeuroVive, ContraVir Pharmaceuticals, Hepion Pharmaceuticals, among other domestic and global players. Segmentations: Population Type (Children and Adults) Drug Type (Branded & Generics), Route of Administration (Oral, Parenteral) End User (Hospitals, Specialty Clinics and Others) Distribution Channel (Hospital Pharmacies, Retail Pharmacies, online Pharmacies and Others) Provided for Major Regions as Follows: North America (USA, Canada and Mexico) Europe (Germany, France, the United Kingdom, Netherlands, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, rest of countries, etc.) Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Nigeria, and South Africa) Some Notable Report Offerings: – We will provide you an analysis of the extent to which this market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better. – We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others. – Also, this report will help you to identify any trends to forecast growth rates. – The analyzed report will forecast the general tendency for supply and demand. Get Complete Details with TOC For Free @ https://www.databridgemarketresearch.com/toc/?dbmr=global-cyclophilin-inhibitors-therapeutics-market Cyclophilin inhibitors therapeutics market is segmented on the basis of indication, population type, drug type, treatment type, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. On the basis of indication, the cyclophilin inhibitors therapeutics market is segmented into HCV1, HCV2, HCV3, HCV4, HCV5, and HCV6. On the basis of population type, the cyclophilin inhibitors therapeutics market is segmented into children and adults. On the basis of drug type, the cyclophilin inhibitors therapeutics market is segmented into, branded and  generics . On the basis of end user, the cyclophilin inhibitors therapeutics market is segmented into Hospitals, specialty clinics and others. On the basis of distribution channel, the cyclophilin inhibitors therapeutics market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. Advantages of the Study -To depict and estimate the at-home testing packs market, as far as worth, by measure, item type, and industry. -To deliberately profile vital participants and completely break down their market position regarding positioning and center abilities, and detail the serious scene for market pioneers -Item Development/Innovation: Detailed bits of knowledge on the item endorsements, R&D exercises, and item dispatches in the at-home testing units market -Methodologies of central participants and item contributions -Top to bottom market division Some Major Points in TOC: Chapter 1. Report Overview Chapter 3. Market Share by Key Players Chapter 4. Breakdown Data by Type and Application Chapter 5. Market by End Users/Application Chapter 6. COVID-19 Outbreak: XYZ Industry Impact Chapter 7. Opportunity Analysis in Covid-19 Crisis Chapter 9. Market Driving Force Key Offerings: -Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities  -Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography Complete Report Is Available (Including Full TOC, List Of Tables & Figures, Graphs, And Chart)@ https://www.databridgemarketresearch.com/reports/global-cyclophilin-inhibitors-therapeutics-market Reason to Buy: Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments. Highlights key business priorities in order to assist companies to realign their business strategies. The key findings and recommendations highlight crucial progressive industry trends thereby allowing players to develop effective long-term strategies. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals. Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate. Top Trending Reports:

NeuroVive Frequently Asked Questions (FAQ)

  • Where is NeuroVive's headquarters?

    NeuroVive's headquarters is located at Medicon Village, Lund.

  • What is NeuroVive's latest funding round?

    NeuroVive's latest funding round is PIPE.

  • Who are the investors of NeuroVive?

    Investors of NeuroVive include Hadean Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.